Clinical Trial Update: Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating panobinostat in relapsed or refractory acute lymphoblastic leukemia or acute myeloid leukemia was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-08-28